EUR/USD continues its rebound near 1.1615 in a neutral trend, with thin holiday trading and weak Eurozone data keeping the pair capped below key resistance at 1.1720.
Full FDA approval for one of its drugs, an excellent earnings report, and a deep pipeline support the bullish trend. Is there more room to the upside for Amgen?